Risk factors
Inmune Bio (INMB) risk factors
Item 1A of every Inmune Bio, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors58 risks39 new31 dropped16 reworded
Inmune Bio faces going concern doubts with an accumulated deficit of $209,037,000 and cash of $24.8 million. Regulatory dependence centers on CORDStrom for RDEB and potential competitors' approvals. Capital-raising limits apply while public float remains below $75.0 million.
Filed Mar 30, 2026 - FY2024 10-K risk factors50 risks
The company faces an accumulated deficit of $163,104,000 with a going concern warning and relies on third-party manufacturers.
Filed Mar 27, 2025